AstraZeneca Bolsters Pipeline with Neogene Therapeutics and C4X Discovery Deals

By Lucy Haggerty & Amit Kaushik

Pharma Deals Review: Vol 2022 Issue 12 (Table of Contents)

Published: 9 Dec-2022

DOI: 10.3833/pdr.v2022.i12.2752     ISSN: 1756-7874

Section: Mergers & Acquisitions



Hoping to enter the cell therapy space, AstraZeneca has agreed to acquire Neogene Therapeutics in a deal worth up to US$320 M...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details